| Intravitreal MPTP drives neuroinflammation and retinal ganglion cell loss with oral nicotinamide treatment providing a robust neuroprotection P Williams, A Rombaut, D Jovancevic, A Nicol, R Brautaset, DI Finkelstein, ... Investigative Ophthalmology & Visual Science 65 (7), 1468-1468, 2024 | | 2024 |
